Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
1,638.00
-15.10 (-0.91%)
Oct 8, 2025, 12:55 PM IST
NSE:SUNPHARMA Revenue
Sun Pharmaceutical Industries had revenue of 138.51B INR in the quarter ending June 30, 2025, with 9.47% growth. This brings the company's revenue in the last twelve months to 537.77B, up 9.28% year-over-year. In the fiscal year ending March 31, 2025, Sun Pharmaceutical Industries had annual revenue of 525.78B with 8.42% growth.
Revenue (ttm)
537.77B
Revenue Growth
+9.28%
P/S Ratio
7.38
Revenue / Employee
12.51M
Employees
43,000
Market Cap
3,966.34B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 525.78B | 40.82B | 8.42% |
Mar 31, 2024 | 484.97B | 46.11B | 10.51% |
Mar 31, 2023 | 438.86B | 52.31B | 13.53% |
Mar 31, 2022 | 386.54B | 51.56B | 15.39% |
Mar 31, 2021 | 334.98B | 6.61B | 2.01% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Divi's Laboratories | 96.52B |
Cipla | 274.80B |
Apollo Hospitals Enterprise | 225.51B |
Mankind Pharma | 129.10B |
Zydus Lifesciences | 236.08B |
Fortis Healthcare | 80.94B |
Alkem Laboratories | 133.04B |
Aurobindo Pharma | 320.25B |
Sun Pharmaceutical Industries News
- 7 days ago - Sun Pharma shares rally nearly 3% as Citi reiterates ‘Buy’ rating, says pricing overhangs now resolved after Pfizer deal - Business Upturn
- 7 days ago - [Brokerage Calls] Stocks to watch on October 1: Ultratech Cement, Muthoot Finance, Manappuram Finance, Amber, Syrma SGS, Sun Pharma and more - Business Upturn
- 7 days ago - Citi bullish on Sun Pharma shares, says MFN and pricing overhangs now resolved after Pfizer deal - Business Upturn
- 7 days ago - Stock Market Live Updates Today, October 1: Adani Enterprises, Power Grid, Adani Green, L&T Technology in focus - Business Upturn
- 7 days ago - Top stocks to watch today, October 1: Adani Enterprises, Sun Pharma, L&T Technology, Adani Green and more - Business Upturn
- 11 days ago - Trump's 100% tariffs on branded drugs: Indian generics spared but poses risks for pharma sector – Explained - The Times of India
- 11 days ago - Not a med emergency: Generic pharma cos spared from harm - The Times of India
- 12 days ago - Trump’s 100% tariffs on branded drugs: Which Indian pharma stocks are most vulnerable? Experts weigh in - The Times of India